Gender Identity Research & Education Society

GIRES is a UK wide organisation whose purpose is to improve the lives of trans and gender diverse people of all ages, including those who are non-binary and non-gender.

GIRES is a volunteer operated membership charity that, in collaboration with the other groups in its field, hears, helps, empowers and gives a voice to trans and gender diverse individuals, including those who are non-binary and non-gender, as well as their families.

We use evidence from individuals’ lived experiences, combined with scientific research into gender identity development, to educate all those who are able to improve trans and gender diverse individuals’ wellbeing. We contribute to policy development regarding equality and human rights for individuals, especially in healthcare.

We also deliver training, e-learning and information to public and private sector organisations, including supporting trans and gender diverse employees or students.

Please download our leaflet, Information and support for trans, non-binary and non-gender people (PDF, 525KB), for a starting point of discovery.


Ban Converson Therapy:  Goverment Consultation – Closes 10th December

17th November 2021
BCT Artwork
The UK Government has released its proposals for how it intends to ban conversion therapy in legislation, and now they are consulting on the details.
This is our chance to make sure the ban is comprehensive and has no exemptions, so that no LGBTQIA+ person is subjected to this abuse.

Gender Inclusion Network

5th October 2021

This release is distributed by Trans media Watch on behalf of the Gender Inclusion Network:

The Gender Inclusion Network (GIN), a major new global movement, dedicated to countering anti-trans propaganda at home and abroad, and spear-headed by academics in UK universities, was launched this week by Professor Sally Hines, Chair of Sociology at the University of Sheffield and Dr. Natacha Kennedy, Lecturer in Education at Goldsmiths, University of London. Read more

Joint Letter from USPATH and WPATH

12th October 2021

USPATH and WPATH Logos     

The United States Professional Association for Transgender Health (USPATH) and the World Professional Association for Transgender Health (WPATH) stand behind the appropriate care of transgender and gender diverse youth, which includes, when indicated, the use of “puberty blockers” such as gonadotropin releasing hormone analogs and other medications to delay puberty, and, when indicated, the use of gender- affirming hormones such as estrogen or testosterone. Guidelines for the assessment of transgender and gender diverse youth, as well as for the use of pubertal delay and gender affirming hormone medications have been published by reputable professional bodies, including the Endocrine Society, the World Professional Association for Transgender Health, and the American Psychiatric Association.

USPATH and WPATH support scientific discussions on the use of pubertal delay and hormone therapy for transgender and gender diverse youth. We believe that such discussions should occur among experts and stakeholders in this area, based on scientific evidence, and in fora such as peer-reviewed journals or scientific conferences, and among colleagues and experts in the assessment and care of transgender and gender diverse youth. USPATH and WPATH oppose the use of the lay press, either impartial or of any political slant or viewpoint, as a forum for the scientific debate of these issues, or the politicization of these issues in any way. Furthermore, individual decisions about gender- affirming interventions and treatments for transgender and gender diverse youth should be made only among the patient, their parent(s) or guardian(s), their medical and mental health provider(s), and any other identified stakeholders on a case-by-case basis, and opposes any attempts to dictate or restrict, by statute, judiciary, or otherwise, access to such treatment when recommended according to accepted standards and guidelines.

The Court of Appeal overturns High Court Judgment

17th September 2021

The Court of Appeal has today told the High Court that it got Bell-v-Tavistock-Judgment made in December 2020, wrong. The decision today has reinstated the test of Gillick and re-emphasised that it is for the clinician together with the patient and the family to make decisions on a case-by-case basis. It was not for the court to make generalisations about consent at different ages, nor should the court be routinely part of the consent process for puberty blockers. The Court of Appeal full and summary judgements: Bell-v-Tavistock-judgment-170921 Court of Appeal Judgment and Bell-v-Tavistock-judgment-170921 Court of Appeal Summary 


Terry Reed OBE, JP, BA (Hons), MCSP, SRP, Grad. Dip. Phys.

On 20th June, 2021, Terry Reed finally lost her long battle with Cancer and we, GIRES, and the wider transgender community, lost one of their fiercest, and most able advocates.

Terry entered the field of gender advocacy in 1997, when she and her husband Bernard, helped their gender diverse daughter win a landmark sex discrimination case. They then established GIRES and have been active ever since. In particular, Terry has been a member of WPATH and has been instrumental in several positive changes to transgender health care best practise. Her grit and determination meant she never gave up on the causes close to her heart, or on life. She was still contributing actively, to the work of GIRES, to the very end.

Everyone who’s life she touched felt enriched by knowing her. She will leave a vacuum in our lives that can never be filled. Our thoughts turn to Bernard, her loving husband and to her surviving family, in this time of their great loss, but Terry will live for ever in our memories, where she will be held with love, respect and gratitude.

Cat Burton


Celebrating Infinitely Diverse Gender Expressions

A few of GIRES’ friends colleagues and supporters.

Together Logo


Galop logo

The National LGB&T Partnership

TGEU logo

LGBT Foundation Logo